EUVIMEDEUVIMED entdecken
Crossref

MicroRNAs as Regulators of Interleukin-6 Expression in Patients with Rheumatoid Arthritis

P. A. Shesternya, A. D. Chernova, N. A. Shnayder

Ural Medical Journal · 18.08.2026 · 25 (4) · 151-174

DOI: 10.52420/umj.25.4.151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ural Medical Journal, online erschienen am 18.08.2026. Verfasst von P. A. Shesternya und 2 weiteren Autor:innen. Die Arbeit nennt 69 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-6 (IL-6) is a prototype cytokine with pleiotropic and excessive functional activity. It regulates inflammatory infiltrate maturation, promotes neutrophil migration and mononuclear cell infiltration, and acts as a chemoreceptor for monocytes in the inflammation focus. These mechanisms are crucial in rheumatoid arthritis (RA) development and therapy. Small non-coding ribonucleic acids (microRNAs) can regulate IL-6 levels in peripheral blood and the inflammation focus by targeting the IL6 gene expression. Understanding the role of microRNAs in RA can help develop innovative diagnostic methods and personalized treatment approaches. This review aims to update knowledge on epigenetic biomarkers of RA and systematize the results of clinical studies evaluating the relationship between circulating microRNA expression and circulating IL-6 levels in RA patients. The authors searched PubMed, ClinicalKey, Scopus, Cochrane Database, Google Scholar, and eLIBRARY.ru for relevant publications using specific keywords and their combinations. Publications from 2014 to 2025, including original clinical studies of RA, were analyzed. This descriptive review demonstrates that circulating microRNAs can be considered promising molecular biomarkers of RA. However, implementing epigenetic study results into routine rheumatological practice remains challenging due to the ambiguous results of previous studies and the necessity to account for both direct and inverse relationships between changes in specific circulating microRNAs and IL-6 levels in the blood of RA patients.

Zitieren

APA

Shesternya, P. A., Chernova, A. D., & Shnayder, N. A. (2026). MicroRNAs as Regulators of Interleukin-6 Expression in Patients with Rheumatoid Arthritis. Ural Medical Journal, 25(4), 151-174. https://doi.org/10.52420/umj.25.4.151

Vancouver

Shesternya PA, Chernova AD, Shnayder NA. MicroRNAs as Regulators of Interleukin-6 Expression in Patients with Rheumatoid Arthritis. Ural Medical Journal. 2026;25(4):151-174. doi:10.52420/umj.25.4.151

BibTeX
@article{Shesternya2026,
  author = {Shesternya, P. A. and Chernova, A. D. and Shnayder, N. A.},
  title = {MicroRNAs as Regulators of Interleukin-6 Expression in Patients with Rheumatoid Arthritis},
  journal = {Ural Medical Journal},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {151--174},
  doi = {10.52420/umj.25.4.151}
}
Kostenlos starten →